Latest European Union Stories
- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical
OnRamp, a high security hosting company based in Austin, TX, has announced that the company recently achieved self-certification under the U.S.-EU Safe Harbor framework. Austin,
Jazz Pharmaceuticals to own worldwide rights to defibrotide at closing DUBLIN, July 2, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company
Differences in coastline demarcation rules between EU countries have immense implications on the implementation of the Barcelona Protocol on ICZM ATHENS, Greece, July 2, 2014 /PRNewswire/
NAI Responds to Former Secretary of Transportation Ray LaHood Distorted Op-ED WASHINGTON, June 27, 2014 /PRNewswire/ -- Norwegian Air International's application to operate to the
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
BRUSSELS, June 26, 2014 /PRNewswire/ -- The Conference Board Leading Economic Index(® )(LEI) for the Euro Area increased 0.3 percent in May 2014 to 111.7 (2004=100), following a 0.2
STOCKHOLM and CHESTERBROOK, Pa., June 25, 2014 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) and Auxilium Pharmaceuticals,
Drugmakers for the first time must now report adverse drug reactions (ADRs) caused by their products in all uses, including off-label use.
LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.